Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127336681 | 12733668 | 1 | I | 20160701 | 20160907 | 20160912 | 20160912 | EXP | GB-MHRA-EYC 00144634 | GB-009507513-1609GBR004143 | MERCK | 87.00 | YR | F | Y | 0.00000 | 20160912 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127336681 | 12733668 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | IN EVENING. | N | U | 20829 | 10 | MG | TABLET | QD | ||||
| 127336681 | 12733668 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | REDUCING REGIME STARTED BYDERMATOLOGIST 25 MG REDUCING BY 5 MG EVERY 3 DAYS TO ZERO | U | 0 | TABLET | ||||||||
| 127336681 | 12733668 | 3 | C | BECLOMETHASONE DIPROPIONATE | BECLOMETHASONE DIPROPIONATE | 1 | Nasal | 0 | NASAL SPRAY | ||||||||||
| 127336681 | 12733668 | 4 | C | CETIRIZINE HYDROCHLORIDE. | CETIRIZINE HYDROCHLORIDE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 127336681 | 12733668 | 5 | C | CETRABEN EMOLLIENT CREAM | 2 | 0 | CREAM | ||||||||||||
| 127336681 | 12733668 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | TABLET | |||||||||||
| 127336681 | 12733668 | 7 | C | ASACOL | MESALAMINE | 1 | 0 | ||||||||||||
| 127336681 | 12733668 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127336681 | 12733668 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | CAPSULE | |||||||||||
| 127336681 | 12733668 | 10 | C | Salbutamol | ALBUTEROL | 1 | Respiratory (inhalation) | INHALER | 0 | ||||||||||
| 127336681 | 12733668 | 11 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | UNK, PRN | 0 | |||||||||||
| 127336681 | 12733668 | 12 | C | White parafin | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127336681 | 12733668 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127336681 | 12733668 | DE |
| 127336681 | 12733668 | HO |
| 127336681 | 12733668 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127336681 | 12733668 | Dyspnoea | |
| 127336681 | 12733668 | Eosinophilic granulomatosis with polyangiitis | |
| 127336681 | 12733668 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127336681 | 12733668 | 1 | 201601 | 0 | ||
| 127336681 | 12733668 | 2 | 201606 | 0 |